Biofeedback for Gastrointestinal Disorders
Excerpt
Biofeedback refers to a collection of techniques in which a physiologic activity is monitored and information concerning unconscious bodily functions is provided instantly by audio or visual instruments so that a patient may gain control over these functions. The patient is instructed to use a number of strategies (for example, sensations, thoughts, or feelings) to produce a desired change in physiologic functioning and to use whichever technique appears successful. The rationale underlying biofeedback assumes that the physiologic activity being monitored is causally related to a clinical problem and that alteration of the physiologic activity can lead to resolution of that
This 100-word excerpt has been provided in the absence of an abstract.
Acknowledgments
ACKNOWLEDGMENTS: The Clinical Efficacy Assessment Project (CEAP) of the American College of Physicians is designed to evaluate and inform College members and others about the safety and efficacy of diagnostic and therapeutic modalities. Evaluation of technologies begins with a notice in the Annals of Internal Medicine and the ACP Observer inviting comments. Appropriate members of the Council of Medical Societies and the Council of Subspecialty Societies as well as other experts are asked to review technologies. The CEAP statements thus represent a synthesis of the literature and expert opinion and are intended to reflect the current state-of-the-art knowledge concerning a technology. Statements may be reconsidered as new information becomes available.
Article and Author Information
-
↵* This paper was authored by Peter M. Marzuk, M.D., and was developed for the Health and Public Policy Committee by the Clinical Efficacy Assessment Subcommittee: Donald E. Olson, M.D., Chairman; David Banta, M.D.; Howard S. Frazier, M.D.; Richard B. Hornick, M.D.; Seymour Perry, M.D.; and Willis C. Maddrey, M.D. Members of the Health and Public Policy Committee for the 1984-85 term include Edwin P. Maynard III, M.D., Chairman; John H. Eisenberg, M.D.; Richard G. Farmer, M.D.; Daniel D. Federman, M.D.; John R. Hogness, M.D.; Leo E. Hollister, M.D.; Charles E. Lewis, M.D.; Donald E. Olson, M.D.; Malcolm L. Peterson, M.D.; Theodore B. Schwartz, M.D.; and Helen L. Smits, M.D. This paper was adopted by the Executive Committee of the Board of Regents on 13 September 1984.
-
Grant support: The development of this paper by the Clinical Efficacy Assessment Project was funded by the John A. Hartford Foundation.
-
▸Requests for reprints should be addressed to Linda Johnson White; Clinical Efficacy Assessment Project, Department of Health and Public Policy, American College of Physicians, 4200 Pine Street; Philadelphia, PA 19104.
Most Read
